Metabolic fatty liver disease
Conditions
Interventions
Sponsors
Shuguang Hospital affiliated to Shanghai Universtiy of Traditonal Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Meet MAFLD diagnostic criteria; 2. ALT and AST are 5 times lower than the upper limit of normal; 3. Between the ages of 18 and 65 years old, regardless of gender; 4. Not taking drugs related to THE treatment of MAFLD; 5. Signed informed consent. 5) Signing the informed consent.
Exclusion criteria
Exclusion criteria: 1. Other acute or chronic liver diseases; 2. Patients with serious primary diseases such as heart, brain, kidney and hematopoietic system; 3. Patients with acute fatty liver of pregnancy, lipid deposition disease, focal fatty liver, hepatic adipose tumor, etc.; 4. Psychopaths; 5. Women who are pregnant or trying to become pregnant, breast-feeding women; 6. Unstable body weight (change > 5% in the first 3 months); 7. Patients with diabetes who are taking insulin or oral hypoglycemic drugs; 8. Current use of weight loss medications (e.g. Orlistat); 9. Patients with anaphylactic specific constitution; 10. Those who cannot strictly follow the treatment plan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MRI determination of proton density and fat content; | — |
Secondary
| Measure | Time frame |
|---|---|
| Instantaneous elastic hardness test of liver; | — |
Countries
China
Contacts
Public ContactSun Xuehua
Shuguang Hospital affiliated to Shanghai Universtiy of Traditonal Chinese Medicine
Outcome results
None listed